Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-09 Sale |
2021-11-10 4:06 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C Executive Chair |
663,881 | $82.26 | $54,611,362 | 591,138 (Indirect Direct) |
View |
| 2021-11-04 Sale |
2021-11-05 4:24 pm |
Merck & Co. Inc. | MRK | DeLuca Richard R. EVP&Pres, Merck Animal Heallth |
29,782 | $90.4 | $2,692,299 | 177,650 (Indirect Direct) |
View |
| 2021-11-04 Sale |
2021-11-05 4:22 pm |
Merck & Co. Inc. | MRK | Litchfield Caroline EVP & CFO |
18,335 | $91 | $1,668,503 | 24,114 (Direct) |
View |
| 2021-11-03 Sale |
2021-11-04 4:19 pm |
Merck & Co. Inc. | MRK | Karachun Rita A Sr. VP Fince-Global Controller |
25,000 | $88.45 | $2,211,215 | 52,796 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:11 pm |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP, Chief Patient Officer |
96,270 | $87.91 | $8,462,682 | 71,691 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-02 6:16 pm |
Merck & Co. Inc. | MRK | Clyburn Frank EVP & Pres ? Human Health |
39,762 | $87.87 | $3,493,879 | 118,723 (Indirect Direct) |
View |
| 2021-10-29 Sale |
2021-11-02 6:14 pm |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat Exe V-P & Pres. MMD |
24,619 | $87.32 | $2,149,731 | 108,358 (Direct) |
View |
| 2021-10-29 Sale |
2021-11-02 6:12 pm |
Merck & Co. Inc. | MRK | DeLuca Richard R. EVP&Pres, Merck Animal Heallth |
135,405 | $87.56 | $11,856,265 | 118,086 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-01 Exercise |
2022-05-03 4:17 pm |
2021-05-01 2023-05-01 |
Merck & Co. Inc. | MRK | Karachun Rita A Sr. VP Fince-Global Controller |
928 | $0 | 40,817 (Direct) |
View |
| 2022-05-01 Tax Withholding |
2022-05-03 4:17 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Karachun Rita A Sr. VP Fince-Global Controller |
318 | $88.69 | 40,817 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:17 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Karachun Rita A Sr. VP Fince-Global Controller |
928 | $88.69 | 40,817 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:16 pm |
2021-05-01 2023-05-01 |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus SVP, U.S. Market |
866 | $0 | 14,528 (Direct) |
View |
| 2022-05-01 Tax Withholding |
2022-05-03 4:16 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus SVP, U.S. Market |
427 | $88.69 | 14,528 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:16 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus SVP, U.S. Market |
866 | $88.69 | 14,528 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:13 pm |
2021-05-01 2023-05-01 |
Merck & Co. Inc. | MRK | Klobuchar Michael A EVP - Chief Strategy Officer |
866 | $0 | 16,862 (Direct) |
View |
| 2022-05-01 Tax Withholding |
2022-05-03 4:13 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Klobuchar Michael A EVP - Chief Strategy Officer |
427 | $88.69 | 16,862 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:13 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Klobuchar Michael A EVP - Chief Strategy Officer |
866 | $88.69 | 16,862 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:11 pm |
2021-05-01 2023-05-01 |
Merck & Co. Inc. | MRK | Garay Arpa SVP Human Health Global Mktg. |
866 | $0 | 1,775 (Direct) |
View |
| 2022-05-01 Tax Withholding |
2022-05-03 4:11 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Garay Arpa SVP Human Health Global Mktg. |
247 | $88.69 | 1,775 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:11 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Garay Arpa SVP Human Health Global Mktg. |
866 | $88.69 | 1,775 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 1:41 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
366 | $82.05 | 112,461 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 1:39 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Seidman Christine E Director |
198 | $82.05 | 7,462 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 1:38 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
137 | $82.05 | 85,815 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 1:35 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Coe Mary Ellen Director |
396 | $82.05 | 13,355 (Direct) |
View |
Ownership |
2022-03-10 7:17 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus SVP, U.S. Market |
0 | $0 | 106,894 (Direct) |
View |
Ownership |
2022-03-10 7:15 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Garay Arpa SVP Human Health Global Mktg. |
0 | $0 | 60,939 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:35 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Zachary Jennifer EVP, General Counsel |
18,420 | $73.51 | 53,419 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:32 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
1,660 | $73.51 | 8,604 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:29 pm |
N/A N/A |
Merck & Co. Inc. | MRK | MIZELL STEVEN EVP, Chief HR Officer |
14,571 | $73.51 | 40,144 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Litchfield Caroline EVP & CFO |
2,429 | $73.51 | 26,556 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:24 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
3,023 | $73.51 | 15,462 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:22 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Klobuchar Michael A EVP - Chief Strategy Officer |
2,994 | $73.51 | 15,546 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:19 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Karachun Rita A Sr. VP Fince-Global Controller |
3,478 | $73.51 | 39,277 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:17 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP, Chief Patient Officer |
9,550 | $73.51 | 48,712 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:15 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C Executive Chair |
119,488 | $73.51 | 710,665 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:12 pm |
N/A N/A |
Merck & Co. Inc. | MRK | DeLuca Richard R. EVP&Pres, Merck Animal Heallth |
15,966 | $73.51 | 135,063 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:09 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat Exe V-P & Pres. MMD |
19,836 | $73.51 | 112,981 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:06 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Davis Robert M CEO & President |
29,896 | $73.51 | 247,593 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 11:13 am |
N/A N/A |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
477 | $76.53 | 8,149 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 11:13 am |
N/A N/A |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
1,202 | $76.53 | 8,149 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 11:13 am |
2021-02-10 2023-02-10 |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
1,202 | $0 | 8,149 (Direct) |
View |
| 2021-02-10 Exercise |
2022-02-11 4:11 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
1,167 | $75.04 | 5,528 (Direct) |
View |
| 2021-02-10 Exercise |
2022-02-11 4:11 pm |
2021-02-10 2023-02-10 |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
1,167 | $0 | 5,528 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2022-02-11 4:11 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
467 | $75.04 | 5,528 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:13 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Coe Mary Ellen Director |
424 | $76.64 | 12,852 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:11 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
147 | $76.64 | 84,994 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:09 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Seidman Christine E Director |
212 | $76.64 | 7,205 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
391 | $76.64 | 111,152 (Direct) |
View |
| 2021-11-09 Exercise |
2021-11-10 4:06 pm |
2014-05-06 2023-05-05 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C Executive Chair |
663,881 | $0 | 591,138 (Direct) |
View |
| 2021-11-04 Exercise |
2021-11-05 4:24 pm |
2016-05-01 2025-04-30 |
Merck & Co. Inc. | MRK | DeLuca Richard R. EVP&Pres, Merck Animal Heallth |
29,782 | $0 | 177,650 (Direct) |
View |
| 2021-11-04 Exercise |
2021-11-05 4:22 pm |
2015-05-02 2024-05-01 |
Merck & Co. Inc. | MRK | Litchfield Caroline EVP & CFO |
22,683 | $0 | 24,114 (Direct) |
View |
| 2021-05-04 Option Award |
2021-11-04 4:24 pm |
2024-05-04 2024-05-04 |
Merck & Co. Inc. | MRK | DeLuca Richard R. EVP&Pres, Merck Animal Heallth |
26,319 | $0 | 26,319 (Direct) |
View |
| 2021-05-04 Option Award |
2021-11-04 4:21 pm |
2024-05-04 2024-05-04 |
Merck & Co. Inc. | MRK | Clyburn Frank EVP & Pres ? Human Health |
39,479 | $0 | 39,479 (Direct) |
View |
| 2021-11-03 Exercise |
2021-11-04 4:19 pm |
2017-05-10 2026-05-09 |
Merck & Co. Inc. | MRK | Karachun Rita A Sr. VP Fince-Global Controller |
25,000 | $0 | 52,796 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:11 pm |
2018-05-05 2027-05-04 |
Merck & Co. Inc. | MRK | Gerberding Julie L. EVP, Chief Patient Officer |
96,270 | $0 | 71,691 (Direct) |
View |
| 2021-10-30 Tax Withholding |
2021-11-02 6:16 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Clyburn Frank EVP & Pres ? Human Health |
1,162 | $88.05 | 118,723 (Direct) |
View |
| 2021-10-30 Exercise |
2021-11-02 6:16 pm |
2019-10-30 2021-10-30 |
Merck & Co. Inc. | MRK | Clyburn Frank EVP & Pres ? Human Health |
42,120 | $0 | 118,723 (Direct) |
View |
| 2021-10-30 Exercise |
2021-11-02 6:16 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Clyburn Frank EVP & Pres ? Human Health |
2,358 | $88.05 | 118,723 (Direct) |
View |
| 2021-10-29 Exercise |
2021-11-02 6:14 pm |
2014-05-06 2023-05-05 |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat Exe V-P & Pres. MMD |
24,619 | $0 | 108,358 (Direct) |
View |
| 2021-10-29 Exercise |
2021-11-02 6:12 pm |
2014-05-06 2023-05-05 |
Merck & Co. Inc. | MRK | DeLuca Richard R. EVP&Pres, Merck Animal Heallth |
135,405 | $0 | 118,086 (Direct) |
View |
| 2021-10-30 Tax Withholding |
2021-11-02 6:11 pm |
N/A N/A |
Merck & Co. Inc. | MRK | MIZELL STEVEN EVP, Chief HR Officer |
2,323 | $88.05 | 25,573 (Direct) |
View |
| 2021-10-30 Exercise |
2021-11-02 6:11 pm |
2019-10-30 2021-10-30 |
Merck & Co. Inc. | MRK | MIZELL STEVEN EVP, Chief HR Officer |
4,715 | $0 | 25,573 (Direct) |
View |
| 2021-10-30 Exercise |
2021-11-02 6:11 pm |
N/A N/A |
Merck & Co. Inc. | MRK | MIZELL STEVEN EVP, Chief HR Officer |
4,715 | $88.05 | 25,573 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-01 11:38 am |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
399 | $75.11 | 109,900 (Direct) |
View |